An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.

The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.

Read the full article

References

Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).

Share this

Related Posts

Exploring the Impact of Tinnitus on Work Productivity

How Well Do Parents and Professionals Know Their Child’s Cochlear Implant?

Newborn Hearing Screenings Made Easier: Why Did We Never Think of This?

Recent Posts

Human ear hears sounds, sound wave, 3d rendering. 3d illustration.

Exploring the Impact of Tinnitus on Work Productivity

Over 50 million people in the United States experience tinnitus; nearly half of those individuals struggle with it, and some even perceive it as debilitating (American Tinnitus…

Read More
Sign of U.S. Department of Education in Washington D.C.

Federal Judge Blocks Key Portion of Student Loan Rule: Department Includes Professional Degree Status for Audiology Programs

Audiology students received an important, though temporary, victory after a federal court blocked a key provision of the U.S. Department of Education’s new student loan…

Read More

Act Now: Contact Your Senators to Protect Future Audiologists

The Senate is expected to vote Thursday, June 25, on the Congressional Review Act (CRA) resolution to overturn the Department of Education’s student loan rule….

Read More